References
Bolland M, Grey A, Reid IR (2013) Calcium supplements and cardiovascular disease risk in the Women’s Health Initiative (letter). Osteoporos Int. doi:10.1007/s00198-013-2356-z
Prentice RL, Pettinger MB, Jackson RD, Wactawski-Wende J, LaCroix AZ, Anderson GL, Chlebowski RT, Manson JE, Van Horn L, Vitolins MZ, Datta M, LeBlanc ES, Cauley JA, Rossouw JE (2013) Health risks and benefits from calcium and vitamin D supplementation: Women’s Health Initiative clinical trial and cohort study. Osteoporos Int 24:567–580. doi:10.1007/s00198-012-2224-2
Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ 342:d2040. doi:10.1136/bmj.d2040
Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, Heckbert SR, Johnson KC, Manson JE, Sidney S, Trevisan M, for the Women’s Health Initiative Investigators (2007) Cardiovascular disease in women. Circulation 115:846–854
Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, Reid IR (2010) Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341:c3691
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prentice, R.L., Jackson, R.D. & Rossouw, J.E. Calcium supplements and cardiovascular risk in the Women’s Health Initiative: response to Bolland et al.. Osteoporos Int 24, 2373–2374 (2013). https://doi.org/10.1007/s00198-013-2359-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-013-2359-9